WallStSmart

HCA Holdings Inc (HCA)vsOncology Institute Inc (TOI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Holdings Inc generates 17714% more annual revenue ($75.60B vs $424.38M). HCA leads profitability with a 9.0% profit margin vs -15.5%. HCA earns a higher WallStSmart Score of 69/100 (B-).

HCA

Strong Buy

69

out of 100

Grade: B-

Growth: 7.3Profit: 8.0Value: 10.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.71

TOI

Hold

42

out of 100

Grade: D

Growth: 7.3Profit: 2.0Value: 5.0Quality: 5.5
Piotroski: 3/9Altman Z: 0.94
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HCAUndervalued (+59.9%)

Margin of Safety

+59.9%

Fair Value

$1326.31

Current Price

$484.02

$842.29 discount

UndervaluedFair: $1326.31Overvalued

Intrinsic value data unavailable for TOI.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCA5 strengths · Avg: 9.0/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-8.3310/10

Conservative balance sheet, low leverage

Market CapQuality
$108.62B9/10

Large-cap with strong market position

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
44.5%8/10

Earnings expanding 44.5% YoY

TOI2 strengths · Avg: 9.0/10
Debt/EquityHealth
-2.2310/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
21.5%8/10

Revenue surging 21.5% year-over-year

Areas to Watch

HCA1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

TOI4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$288.00M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-6.5%2/10

ROE of -6.5% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.35 suggests the stock is reasonably priced for its growth.

Bull Case : TOI

The strongest argument for TOI centers on Debt/Equity, Revenue Growth. Revenue growth of 21.5% demonstrates continued momentum.

Bear Case : HCA

The primary concerns for HCA are Altman Z-Score.

Bear Case : TOI

The primary concerns for TOI are EPS Growth, Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

HCA profiles as a value stock while TOI is a growth play — different risk/reward profiles.

HCA carries more volatility with a beta of 1.34 — expect wider price swings.

TOI is growing revenue faster at 21.5% — sustainability is the question.

HCA generates stronger free cash flow (870M), providing more financial flexibility.

Bottom Line

HCA scores higher overall (69/100 vs 42/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HCA Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

Oncology Institute Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Oncology Institute Inc (ticker: TOI) is a leading healthcare organization committed to revolutionizing cancer care through its expansive network of specialized clinics and advanced treatment options. Focused on improving patient outcomes, the company utilizes cutting-edge technologies and tailored treatment strategies, while actively engaging in clinical trials and partnerships with esteemed research institutions. As the demand for innovative cancer therapies accelerates, TOI is well-positioned to capitalize on its extensive pipeline and deep oncology expertise, solidifying its role as a vital participant in the dynamic healthcare landscape.

Visit Website →

Want to dig deeper into these stocks?